SCHEMBL10184119

SCHEMBL10184119

O=C1C(N(C(=O)COC2CCCC2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.37
▸ OPRK1 P41145 3/20 0.37
▸ OPRL1 P41146 3/20 0.37
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ AGTR2 P50052 2/20 0.35
▸ CCKBR P32239 3/20 0.33
▸ CCKAR P32238 2/20 0.33
▸ IDH1 O75874 2/20 0.33
▸ PTGIR P43119 2/20 0.33
▸ NR1H4 Q96RI1 1/20 0.33
▸ TRPM8 Q7Z2W7 1/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ PTGER3 P43115 1/20 0.33
▸ PTGER2 P43116 1/20 0.33
▸ PTGDR Q13258 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183683 0.90 OPRM1 (0.35) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10183761 0.89 TRPM8 (0.42) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10183299 0.88 OPRM1 (0.40) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10185587 0.88 TRPM8 (0.41) OPRM1OPRK1OPRL1LMNAMAPT
SCHEMBL10183319 0.87 MEN1 (0.43) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10183337 0.87 OPRM1 (0.39) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10184089 0.87 OPRM1 (0.33) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10183638 0.86 OPRM1 (0.35) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10183654 0.86 IDH1 (0.38) OPRM1OPRK1OPRL1LMNATP53
SCHEMBL10185907 0.85 OPRM1 (0.35) OPRM1OPRK1OPRL1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback